Midazolam versus diazepam for the treatment of status epilepticus in pediatric emergency <br><b>Abstract in English</b>
Keywords:
EPILEPSY/drug therapy, ANTICONVULSANTS/administration & dosage, MIDAZOLAM, DIAZEPAM, EMERGENCIES, EMERGENCY SERVICE, HOSPITAL, PEDIATRICS, CHILD, PRESCHOOL, INFANT.Abstract
AIMS: To conduct a review article evaluating midazolam administered by different routes as well as diazepam administered through intravenous and rectal route for treating status epilepticus in children. SOURCE OF DATA: Bibliographic search was conducted on Google Scholar, LILACS, PubMed and SciELO databases, using the key words status epilepticus, seizure, benzodiazepines, midazolam, diazepam, children. SUMMARY OF FINDINGS: Rapid onset treatment of status epilepticus is associated with better results. Diazepam has been the first-line treatment in the last 30 years, despite of known difficulties of venipuncture in infants. Midazolam appears to be an important advance for the quick seizure emergency treatment for its ease administration and rapid action. The ideal drug and route of administration for seizure control in these situations remain uncertain. CONCLUSIONS: If intravenous access is not available, there is evidence that intramuscular, oral or nasal midazolam can be an alternative to diazepam (rectal or intravenous) for treatment of seizures in pediatric emergency.Downloads
Download data is not yet available.
Downloads
Published
2011-12-05
How to Cite
Portela, J. de L., & Piva, J. P. (2011). Midazolam versus diazepam for the treatment of status epilepticus in pediatric emergency <br><b>Abstract in English</b>. Scientia Medica, 21(4), 184–190. Retrieved from https://revistaseletronicas.pucrs.br/ojs/index.php/scientiamedica/article/view/9176
Issue
Section
Review Articles
License
Copyright
The submission of originals to Scientia Medica implies the transfer by the authors of the right for publication. Authors retain copyright and grant the journal right of first publication. If the authors wish to include the same data into another publication, they must cite Scientia Medica as the site of original publication.
Creative Commons License
Except where otherwise specified, material published in this journal is licensed under a Creative Commons Attribution 4.0 International license, which allows unrestricted use, distribution and reproduction in any medium, provided the original publication is correctly cited.
